Inventor
JANSEN HANS-WILLI
DE20 patents
⚠️ This page may combine multiple inventors who share the name “JANSEN HANS-WILLI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA GMBH
13 patentsUS6737423B2May 18, 2004
Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH38 citations92
US6593352B2Jul 15, 2003
Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
AVENTIS PHARMA GMBH41 citations92
US6451781B1Sep 17, 2002
Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH16 citations84
US6825231B2Nov 30, 2004
Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
AVENTIS PHARMA GMBH8 citations74
US6339077B1Jan 15, 2002
Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof
AVENTIS PHARMA GMBH8 citations74
US6979532B2Dec 27, 2005
Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
AVENTIS PHARMA GMBH6 citations71
US6166002ADec 26, 2000
Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics
AVENTIS PHARMA GMBH14 citations71
US6291502B1Sep 18, 2001
Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions
AVENTIS PHARMA GMBH4 citations63
US6573288B1Jun 3, 2003
Substituted sulphonyl cyanamides, method for producing same and their use as medicament
AVENTIS PHARMA GMBH5 citations62
US6369069B1Apr 9, 2002
Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
AVENTIS PHARMA GMBH3 citations62
US6617344B2Sep 9, 2003
Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH1 citations52
US6331546B1Dec 18, 2001
Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
AVENTIS PHARMA GMBH0 citations52
US6703411B2Mar 9, 2004
Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AVENTIS PHARMA GMBH0 citations42
HOECHST AG
3 patentsUS6335451B1Jan 1, 2002
Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them
HOECHST AG26 citations92
US6005010ADec 21, 1999
Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
HOECHST AG45 citations92
US6486189B2Nov 26, 2002
Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
HOECHST AG2 citations62
SANOFI AVENTIS DEUTSCHLAND
2 patentsUS7442717B2Oct 28, 2008
Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
SANOFI AVENTIS DEUTSCHLAND4 citations63
US7550257B2Jun 23, 2009
Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
SANOFI AVENTIS DEUTSCHLAND1 citations50